You are currently viewing a new version of our website. To view the old version click .

Hemato, Volume 6, Issue 3

September 2025 - 17 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (17)

  • Review
  • Open Access
1,566 Views
25 Pages

18 September 2025

Complete or partial deletions of chromosome 7 (-7/del7q) represent the most frequent chromosomal abnormalities observed in myeloid neoplasms (MNs) and are associated with a poor prognosis. -7/del7q is observed in 10–15% of adult patients with m...

  • Review
  • Open Access
1 Citations
1,581 Views
13 Pages

17 September 2025

Runt-related transcription factor 1 (RUNX1) is a key transcription factor in hematopoiesis, producing multiple major isoforms, RUNX1A, B, and C, via alternative promoter usage and splicing. These isoforms have distinct roles in hematopoiesis and leuk...

  • Article
  • Open Access
1,181 Views
9 Pages

Survival and Prognostic Factors in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Receiving Supportive Care

  • Christian Ramos Peñafiel,
  • Álvaro Cabrera García,
  • Adolfo Martínez Tovar,
  • Daniela Pérez Sámano,
  • Isle Mendez Lomeli,
  • Ernesto Villagrán Carpintero,
  • Irma Olarte Carrillo,
  • Sayuri Midori Vargas Peña and
  • Adán Germán Gallardo Rodríguez

11 September 2025

Background/Objectives: Adult acute lymphoblastic leukemia (ALL) often has poor outcomes, especially after relapse or treatment failure. Many patients eventually become ineligible for curative treatment and require only supportive care or low-intensit...

  • Article
  • Open Access
1,965 Views
15 Pages

Rare Blood Group Bank in Transfusion Therapy of Patients with Complex Allo-Immunizations: A Single Veneto Center Experience

  • Luca Collodel,
  • Enza Coluccia,
  • Stefania Guaita,
  • Michela Pivetta,
  • Ileana Vaccara and
  • Gianluca Gessoni

8 September 2025

Background: Today, in Western countries, patients with allo-antibodies to high-frequency antigens or with complex antibody mixtures represent one of the most significant challenges in transfusion medicine. Another important aspect is the prevention o...

  • Article
  • Open Access
1,004 Views
13 Pages

miR-429 Acts as a Tumor Suppressor in Multiple Myeloma by Regulating Cell Proliferation

  • Mohamed Abdelkarim,
  • Inès Limam,
  • Emna Berred,
  • Rachid Kharrat,
  • Brigitte Sola and
  • Fatma Ben Aissa-Fennira

26 August 2025

Background/Objectives: Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of abnormal plasma cells in bone marrow, predominantly affecting individuals over 65 years of age. Despite recent therapeutic advances,...

  • Review
  • Open Access
2,850 Views
56 Pages

Multiple Myeloma and Precursor Plasma Cell Disorders: From Emerging Driver Mutations to Current and Future Therapeutic Strategies

  • Henry Sutanto,
  • Pradana Zaky Romadhon,
  • Vembi Rizky Fatmawati,
  • Alief Waitupu,
  • Bagus Aditya Ansharullah,
  • Betty Rachma,
  • Elisa Elisa,
  • Laras Pratiwi and
  • Galih Januar Adytia

18 August 2025

Multiple myeloma (MM) is a malignant plasma cell disorder that evolves from precursor conditions including monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Understanding the biological continuum and the...

  • Review
  • Open Access
3 Citations
1,149 Views
16 Pages

Polyphenols and Chronic Myeloid Leukemia: Emerging Therapeutic Opportunities

  • Claudia Moriello,
  • Chiara De Rosa,
  • Stefania D’Angelo and
  • Perrone Pasquale

15 August 2025

Background/Objectives: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the BCR–ABL fusion gene, whose constitutive tyrosine kinase activity drives leukemogenesis. Although tyrosine kinase inhibitors (TKIs) have...

  • Case Report
  • Open Access
1,443 Views
9 Pages

Rare Coexistence of Atypical Chronic Lymphocytic Leukemia and B-Acute Lymphoblastic Leukemia in a Patient Followed Up for Monoclonal B-Cell Lymphocytosis

  • Fabio Bertani,
  • Francesco Faiella,
  • Claudia Di Franco,
  • Raffaella Milani,
  • Antonella Gualdoni,
  • Cinzia Fulceri and
  • Elena Costa

7 August 2025

Monoclonal B Lymphocytosis (MBL) is considered the pre-malignant state of chronic lymphocytic leukemia (CLL) and atypical chronic lymphocytic leukemia (aCLL). Both entities are rarely found in association with other hematological tumors; still, they...

  • Review
  • Open Access
1 Citations
8,482 Views
15 Pages

4 August 2025

Background/Objectives: Pica, the compulsive ingestion of non-nutritive substances, has long been observed in patients with iron deficiency anemia (IDA). This behavior is particularly noted in adults, including pregnant women, and poses both diagnosti...

  • Case Report
  • Open Access
907 Views
7 Pages

Simultaneous Central Nervous System and Cutaneous Relapse in Acute Myeloid Leukemia

  • Eros Cerantola,
  • Laura Forlani,
  • Marco Pizzi,
  • Renzo Manara,
  • Mauro Alaibac,
  • Federica Lessi,
  • Angelo Paolo Dei Tos,
  • Chiara Briani and
  • Carmela Gurrieri

23 July 2025

Introduction: Acute Myeloid Leukemia (AML) is a hematologic malignancy characterized by the clonal expansion of myeloid progenitors. While it primarily affects the bone marrow, extramedullary relapse occurs in 3–5% of cases, and it is linked to...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hemato - ISSN 2673-6357